These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11138528)

  • 1. Diabetes. Type-righting lessons.
    Bryan J
    Health Serv J; 2000 Nov; 110(5733):suppl 11-2. PubMed ID: 11138528
    [No Abstract]   [Full Text] [Related]  

  • 2. Troglitazone for Type II Diabetes.
    Issues Emerg Health Technol; 1997 Oct; (1):1-4. PubMed ID: 11811200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review.
    Chilcott J; Wight J; Lloyd Jones M; Tappenden P
    Health Technol Assess; 2001; 5(19):1-61. PubMed ID: 11701097
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiazolidinediones in the treatment of type 2 diabetes: a clinician's perspective.
    Buse JB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S710-7. PubMed ID: 11183423
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin: standard therapy following oral hypoglycaemic failure in type 2 diabetes?
    English P
    Br J Hosp Med (Lond); 2013 Apr; 74(4):192-7. PubMed ID: 23571388
    [No Abstract]   [Full Text] [Related]  

  • 6. NICE issues guidance on diabetes treatments.
    Iles A
    BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958096
    [No Abstract]   [Full Text] [Related]  

  • 7. Should future health-care costs be discounted? The case of diabetes in Australia.
    Scuffham PA
    Intern Med J; 2006 Mar; 36(3):148-9. PubMed ID: 16503948
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thiazolidinediones in type 2 diabetes].
    Baum U
    Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of models within economic analysis: focus on type 2 diabetes mellitus.
    Coyle D; Lee KM; O'Brien BJ
    Pharmacoeconomics; 2002; 20 Suppl 1():11-9. PubMed ID: 12036380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR
    Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosiglitazone and type 2 diabetes mellitus.
    Bragg T
    Lancet; 2001 May; 357(9266):1451. PubMed ID: 11360960
    [No Abstract]   [Full Text] [Related]  

  • 12. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thiazolidinediones].
    Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
    Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
    [No Abstract]   [Full Text] [Related]  

  • 14. Rosiglitazone monotherapy and type 2 diabetes.
    Lawrence IG
    Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
    [No Abstract]   [Full Text] [Related]  

  • 15. Applications of economic models in healthcare: the introduction of pioglitazone in Sweden.
    Henriksson F
    Pharmacoeconomics; 2002; 20 Suppl 1():43-53. PubMed ID: 12036383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warner Lambert/Sankyo diabetes drug nears market.
    Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120
    [No Abstract]   [Full Text] [Related]  

  • 17. Honing type 2 diabetes treatment.
    Blackburn G
    Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
    Algenstaedt P; Hamann A
    Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
    [No Abstract]   [Full Text] [Related]  

  • 19. New treatment for adult-onset diabetes.
    Zurlinden J
    Nurs Spectr (Wash D C); 1997 Aug; 7(16):8. PubMed ID: 9439332
    [No Abstract]   [Full Text] [Related]  

  • 20. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
    Böhm S
    MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.